Tom Jones’ Post

ANGLE introduced the Portrait+ CTC staining kit designed to detect, characterize, and count epithelial and mesenchymal cancer cells, even those transitioning between the two—an essential phase linked to cancer progression, drug resistance, and metastasis. Following extensive development, optimization, and validation, the company launched this kit for advanced immunofluorescent staining of circulating tumor cells (CTCs) obtained via Angle's Parsortix technology. This kit utilizes a direct staining method and a finely-tuned dye combination, ensuring strong signal intensity without compromising analytical specificity or sensitivity, according to Angle. Additionally, it incorporates CellKeep slides, enhancing the retention of harvested cells from blood samples for subsequent imaging. #stainingkit #immunofluorescent #imaging